Israeli company 'gets FDA nod' to treat tumors in liver, kidney

|
PrintFind an error? Report us
Israel's IceCure Medical said on Sunday it has received U.S. regulatory approval to expand the use of its cryoablation technology to treat benign and cancerous tumors in livers and kidneys, sending its share price up 30%.
IceCure's treatment uses special needles to inject liquid nitrogen to freeze and destroy tumors without the need for surgery.
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""